NeueHealth, Inc.
NEUE
$6.73
$0.010.15%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.30% | 77.26% | 26.33% | 30.86% | 20.89% |
| Total Depreciation and Amortization | -35.26% | -44.57% | -49.20% | -46.14% | -52.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.97% | -92.40% | 30.17% | 18.84% | 13.49% |
| Change in Net Operating Assets | 97.77% | 89.87% | -348.22% | -1,712.70% | -284.77% |
| Cash from Operations | 95.48% | 81.08% | -70.99% | -149.65% | -1,262.87% |
| Capital Expenditure | 19.47% | 78.66% | 90.60% | 95.39% | 89.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 29,003.37% | 29,003.37% | 29,003.37% | 14,066.28% | -- |
| Other Investing Activities | -100.70% | -102.68% | 37.69% | -51.98% | 379.43% |
| Cash from Investing | -83.31% | -86.14% | 69.63% | -29.09% | 360.55% |
| Total Debt Issued | 83.44% | 17.07% | -60.91% | -78.15% | -78.15% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -99.91% | -99.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -516.71% | -35.40% | -120.82% | -170.98% | -282.60% |
| Cash from Financing | -608.06% | -208.84% | -136.39% | -147.43% | -95.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.81% | 43.66% | -1,538.41% | -452.89% | -278.74% |